Abstract: The invention is a 2-piece electrical connector cover for protecting electrical connectors having a plug and a socket. A first piece has an internal diameter and an external diameter. The internal diameter is frictionally equivalent to the external diameter of the plug, so that the first piece fits snugly on the plug and protects it. The second piece of the electrical connector cover also has an internal and an external diameter. The external diameter of the second piece is frictionally equivalent to the internal diameter of the socket so that the second piece fits snugly into the socket and protects it. The external diameter of the first piece is frictionally equivalent to the external diameter of the second piece, so that the first piece fits snugly into the second piece, thereby holding the two pieces together when they are not being used to protect the electrical connector.

Abstract: Diagnostic methods for the detection of multiple myeloma (MM) and the identification of high-risk patients with multiple myeloma-related plasma proliferative disorders, such as MGUS or SMM, likely to progress to active MM are described. The diagnosis is based on the determination of concentrations of bioactive IL-1? produced by the bone marrow plasma cells of these patients. Also described are therapeutic methods for the treatment of MM and for the chemoprevention of the progression from disorders such as MGUS and SMM to active MM, involving the administration of inhibitors of IL-1?.

Abstract: The invention is a 2-piece electrical connector cover for protecting electrical connectors having a plug and a socket. A first piece has an internal diameter and an external diameter. The internal diameter is frictionally equivalent to the external diameter of the plug, so that the first piece fits snugly on the plug and protects it. The second piece of the electrical connector cover also has an internal and an external diameter. The external diameter of the second piece is frictionally equivalent to the internal diameter of the socket so that the second piece fits snugly into the socket and protects it. The external diameter of the first piece is frictionally equivalent to the external diameter of the second piece, so that the first piece fits snugly into the second piece, thereby holding the two pieces together when they are not being used to protect the electrical connector.

Abstract: Diagnostic methods for the detection of multiple myeloma (MM) and the identification of high-risk patients with multiple myeloma-related plasma proliferative disorders, such as MGUS or SMM, likely to progress to active MM are described; The diagnosis is based on the determination of concentrations of bioactive IL-1? produced by the bone marrow plasma cells of these patients. Also described are therapeutic methods for the treatment of MM and for the chemoprevention of the progression from disorders such as MGUS and SMM to active MM, involving the administration of inhibitors of IL-1?.

Abstract: Diagnostic methods for the detection of multiple myeloma (MM) and the identification of high-risk patients with multiple myeloma-related plasma proliferative disorders, such as MGUS or SMM, likely to progress to active MM are described. The diagnosis is based on the determination of concentrations of bioactive IL-1? produced by the bone marrow plasma cells of these patients. Also described are therapeutic methods for the treatment of MM and for the chemoprevention of the progression from disorders such as MGUS and SMM to active MM, involving the administration of inhibitors of IL-1?.

Abstract: A fusion polypeptide comprising an antibody or a fragment thereof is provided. The fusion polypeptide is useful in a therapeutic composition to treat multiple myeloma.

Abstract: Diagnostic methods for the detection of multiple myeloma (MM) and the identification of high-risk patients with multiple myeloma-related plasma proliferative disorders, such as MGUS or SMM, likely to progress to active MM are described. The diagnosis is based on the determination of concentrations of bioactive IL-1&bgr; produced by the bone marrow plasma cells of these patients. Also described are therapeutic methods for the treatment of MM and for the chemoprevention of the progression from disorders such as MGUS and SMM to active MM, involving the administration of inhibitors of IL-1&bgr;.

Abstract: A fusion polypeptide comprising an antibody or a fragment thereof is provided. The fusion polypeptide is useful in a therapeutic composition to treat multiple myeloma.